EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pathological Classification and Clinical Characteristics of Growth Hormone-Secreting PitNETs

Zhenwei Li, Yinzi Wu, Yike Gao, Ming Feng, Kan Deng, Bing Xing, Wei Lian, Yong Yao, Renzhi Wang, Jian Sun, Xinjie Bao

Neuroendocrinology · 2026

DOI: 10.1159/000552989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuroendocrinology, 2026. Verfasst von Zhenwei Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Chi…. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Growth Hormone-Secreting Pituitary Adenoma, Pituitary Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acromegaly/gigantism is a rare disease primarily caused by growth hormone (GH)-secreting pituitary neuroendocrine tumors (PitNETs). With the update in the WHO 5th edition classification of pituitary tumors, particularly the introduction of the novel PIT1/SF1 co-expressing tumor subtype, our understanding of these neoplasms has significantly advanced. However, systematic pathological classification and clinical characterization studies of GH-secreting PitNETs remain relatively scarce.

Methods

A retrospective study was conducted on 143 patients with acromegaly/gigantism who underwent surgical treatment at Peking Union Medical College Hospital between June 2022 and December 2024. Tumor specimens were re-evaluated for pathological subtyping. Demographic data, radiological characteristics, hormone profiles, immunohistochemical findings, and clinical outcomes were collected and compared among subtypes.

Results

Forty-five cases (32%) were classified as pure GH-secreting tumors, while the remainder showed co-expression of other hormones and transcription factors. Among PIT1-lineage tumors, sparsely granulated somatotroph tumors (SGSTs) demonstrated greater cavernous sinus invasion, larger maximal tumor diameter, lower GH secretion index, and immunostaining intensity, and reduced SSTR2 expression, suggesting a more aggressive biological behavior. Co-expression of prolactin increased the risk of hyperprolactinemia (OR = 2.843), though only 23.7% of mammosomatotroph tumors and 32.6% of mixed somatotroph-lactotroph tumors presented with hyperprolactinemia. Additionally, 19 PIT1/SF1 co-expressing tumors were identified, showing diverse hormonal profiles and significantly higher cavernous sinus invasion compared to PIT1-lineage tumors.

Conclusion

GH-secreting PitNETs exhibit marked heterogeneity in pathological subtypes. Current classification systems require clearer cutoff criteria to improve diagnostic consistency. SGSTs are associated with a more invasive phenotype, warranting close clinical monitoring and long-term follow-up. PIT1/SF1 co-expressing tumors represent a distinct and heterogeneous entity that should be considered in future classification frameworks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsGrowth Hormone-Secreting Pituitary AdenomaPituitary NeoplasmsHumansFemaleRetrospective StudiesMaleAdultMiddle AgedTranscription Factor Pit-1AcromegalyAged

Stichwörter der Autor:innen

AcromegalyGrowth hormoneInvasive pituitary adenomasPituitary neuroendocrine tumorWHO classification

Substanzen

Transcription Factor Pit-1

Autor:innen und Institutionen

  • Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, sunjian@pumch.cn.
  • Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, baoxinjie1@pumch.cn.
  • State Key Laboratory of Common Mechanism Research for Major Diseases, Beijing, China, baoxinjie1@pumch.cn.

Zitieren

APA

Li, Z., Wu, Y., Gao, Y., Feng, M., Deng, K., Xing, B., Lian, W., Yao, Y., Wang, R., Sun, J., & Bao, X. (2026). Pathological Classification and Clinical Characteristics of Growth Hormone-Secreting PitNETs. Neuroendocrinology. https://doi.org/10.1159/000552989

Vancouver

Li Z, Wu Y, Gao Y, Feng M, Deng K, Xing B, et al. Pathological Classification and Clinical Characteristics of Growth Hormone-Secreting PitNETs. Neuroendocrinology. 2026. doi:10.1159/000552989

BibTeX
@article{Li2026,
  author = {Li, Zhenwei and Wu, Yinzi and Gao, Yike and Feng, Ming and Deng, Kan and Xing, Bing and Lian, Wei and Yao, Yong and Wang, Renzhi and Sun, Jian and Bao, Xinjie},
  title = {Pathological Classification and Clinical Characteristics of Growth Hormone-Secreting PitNETs},
  journal = {Neuroendocrinology},
  year = {2026},
  doi = {10.1159/000552989}
}
Kostenlos starten →